Fig. 4From: Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancerCirculating SPARC levels decrease in CT pretreated-lung cancer patients. Box plots showing ECM molecule (COL10A1, SPARC, COL11A1) levels after treatment with chemotherapy before surgery. p = Wilcoxon test p-valueBack to article page